Literature DB >> 698489

A study of thyroid function in psychiatric in-patients.

D G McLarty, W A Ratcliffe, J G Ratcliffe, J G Shimmins, A Goldberg.   

Abstract

The prevalence of abnormal serum total thyroxine (T4) and triiodothyronine (T3) concentrations were determined in 1,206 in-patients in two associated psychiatric hospitals. The biochemical pattern of primary hypothyroidism occurred in five females and one male (prevalence 0.5 per cent), but in only one patient was the diagnosis clinically obvious. Eight patients (all female) were clinically hyperthyroid (prevalence 0.7 per cent), of whom six were previously undiagnosed. There was no evidence that phenothiazines or benzodiazepine therapy had any significant effect on thyroid hormone levels. The small differences in thyroid hormone levels between psychiatric diagnostic groups could be explained by differences in age distribution.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 698489     DOI: 10.1192/bjp.133.3.211

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  5 in total

1.  Thyroid dysfunction and affective illness.

Authors:  E Szabadi
Journal:  BMJ       Date:  1991-04-20

Review 2.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

Review 3.  The effects of drugs on tests of thyroid function.

Authors:  P H Davies; J A Franklyn
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Subclinical hypothyroidism: neurobehavioral features and beneficial effect of L-thyroxine treatment.

Authors:  F Monzani; P Del Guerra; N Caraccio; C A Pruneti; E Pucci; M Luisi; L Baschieri
Journal:  Clin Investig       Date:  1993-05

5.  Subclinical hypothyroidism resulting from autoimmune thyroiditis in female patients with endogenous depression.

Authors:  N Custro; V Scafidi; R Lo Baido; L Nastri; G Abbate; M P Cuffaro; S Gallo; G Vienna; A Notarbartolo
Journal:  J Endocrinol Invest       Date:  1994-09       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.